USD 0.08
(56.51%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2022 | 2.34 Million USD | -48.8% |
2021 | 4.58 Million USD | 87.63% |
2020 | 2.44 Million USD | 61021.9% |
2019 | 4000.00 USD | -20.0% |
2018 | 5000.00 USD | 25.0% |
2017 | 4000.00 USD | -71.43% |
2016 | 14 Thousand USD | -6.67% |
2015 | 15 Thousand USD | 36.36% |
2014 | 11 Thousand USD | -26.67% |
2013 | 15 Thousand USD | 50.0% |
2012 | 10 Thousand USD | 0.0% |
2011 | 10 Thousand USD | 11.11% |
2010 | 9000.00 USD | 125.0% |
2009 | 4000.00 USD | 0.0% |
2008 | 4000.00 USD | -60.0% |
2007 | 10 Thousand USD | -82.76% |
2006 | 58 Thousand USD | 5.45% |
2005 | 55 Thousand USD | -80.5% |
2004 | 282 Thousand USD | -65.23% |
2003 | 811 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q2 | 1.96 Million USD | -7.21% |
2023 Q1 | 2.11 Million USD | -10.0% |
2022 Q1 | 4.46 Million USD | -2.65% |
2022 Q3 | 3.71 Million USD | -8.17% |
2022 FY | 2.34 Million USD | -48.8% |
2022 Q2 | 4.05 Million USD | -9.3% |
2022 Q4 | 2.34 Million USD | -36.86% |
2021 Q4 | 4.58 Million USD | 5.28% |
2021 Q3 | 4.35 Million USD | 4.35% |
2021 FY | 4.58 Million USD | 87.63% |
2021 Q1 | 3.9 Million USD | 59.82% |
2021 Q2 | 4.17 Million USD | 6.86% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 FY | 2.44 Million USD | 61021.9% |
2020 Q4 | 2.44 Million USD | 0.0% |
2020 Q1 | - USD | -100.0% |
2019 Q2 | 4000.00 USD | 0.0% |
2019 Q1 | 4000.00 USD | 0.0% |
2019 Q4 | 1000.00 USD | 0.0% |
2019 FY | 4000.00 USD | -20.0% |
2019 Q3 | 1000.00 USD | -75.0% |
2018 Q4 | 4000.00 USD | 33.33% |
2018 Q3 | 3000.00 USD | 0.0% |
2018 Q2 | - USD | -100.0% |
2018 Q1 | 5000.00 USD | 25.0% |
2018 FY | 5000.00 USD | 25.0% |
2017 Q1 | 4000.00 USD | 33.33% |
2017 FY | 4000.00 USD | -71.43% |
2017 Q3 | 4000.00 USD | 0.0% |
2017 Q4 | 4000.00 USD | 0.0% |
2017 Q2 | - USD | -100.0% |
2016 Q1 | 14 Thousand USD | 75.0% |
2016 FY | 14 Thousand USD | -6.67% |
2016 Q4 | 3000.00 USD | -76.92% |
2016 Q3 | 13 Thousand USD | 0.0% |
2016 Q2 | - USD | -100.0% |
2015 Q3 | - USD | -100.0% |
2015 FY | 15 Thousand USD | 36.36% |
2015 Q1 | 15 Thousand USD | 87.5% |
2015 Q4 | 8000.00 USD | 0.0% |
2015 Q2 | 15 Thousand USD | 0.0% |
2014 Q1 | 11 Thousand USD | -50.0% |
2014 Q3 | 6000.00 USD | -45.45% |
2014 FY | 11 Thousand USD | -26.67% |
2014 Q2 | 11 Thousand USD | 0.0% |
2014 Q4 | 8000.00 USD | 33.33% |
2013 Q1 | 15 Thousand USD | 66.67% |
2013 Q4 | 22 Thousand USD | 0.0% |
2013 FY | 15 Thousand USD | 50.0% |
2013 Q3 | - USD | -100.0% |
2013 Q2 | 15 Thousand USD | 0.0% |
2012 Q1 | 10 Thousand USD | 25.0% |
2012 Q2 | 10 Thousand USD | 0.0% |
2012 Q3 | 19 Thousand USD | 90.0% |
2012 Q4 | 9000.00 USD | -52.63% |
2012 FY | 10 Thousand USD | 0.0% |
2011 FY | 10 Thousand USD | 11.11% |
2011 Q2 | 10 Thousand USD | 0.0% |
2011 Q3 | 16 Thousand USD | 60.0% |
2011 Q4 | 8000.00 USD | -50.0% |
2011 Q1 | 10 Thousand USD | 25.0% |
2010 Q3 | 10 Thousand USD | 11.11% |
2010 FY | 9000.00 USD | 125.0% |
2010 Q4 | 8000.00 USD | -20.0% |
2010 Q1 | 9000.00 USD | 0.0% |
2010 Q2 | 9000.00 USD | 0.0% |
2009 FY | 4000.00 USD | 0.0% |
2009 Q1 | 4000.00 USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2008 Q1 | 4000.00 USD | 0.0% |
2008 FY | 4000.00 USD | -60.0% |
2007 Q1 | 10 Thousand USD | 0.0% |
2007 FY | 10 Thousand USD | -82.76% |
2006 FY | 58 Thousand USD | 5.45% |
2006 Q1 | 58 Thousand USD | 0.0% |
2005 FY | 55 Thousand USD | -80.5% |
2005 Q1 | 55 Thousand USD | 0.0% |
2004 Q1 | 282 Thousand USD | 0.0% |
2004 FY | 282 Thousand USD | -65.23% |
2003 FY | 811 Thousand USD | 0.0% |
2003 Q1 | 811 Thousand USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
American Medical Technologies Inc. | 1.83 Million USD | -27.773% |
Ansell Limited | 3.23 Billion USD | 99.927% |
Ansell Limited | 3.24 Billion USD | 99.928% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 488.98 Million USD | 99.52% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 300.36 Thousand USD | -681.907% |
Psykey, Inc. | 1.72 Million USD | -35.962% |
ConvaTec Group Plc | 3.7 Billion USD | 99.937% |
ConvaTec Group Plc | 3.71 Billion USD | 99.937% |
Encision Inc. | 3.81 Million USD | 38.37% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 651.88 Thousand USD | -260.273% |
LifePoint, Inc. | 8.8 Million USD | 73.34% |
Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 85.281% |
Paradigm Medical Industries, Inc. | 895 Thousand USD | -162.408% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 5.48 Million USD | 57.214% |
Reflect Scientific, Inc. | 2.66 Million USD | 12.003% |
SmileDirectClub, Inc. | 597.06 Million USD | 99.607% |
Sector 10, Inc. | 1000.00 USD | -234755.1% |
Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 99.951% |
SheerVision, Inc. | 837.56 Thousand USD | -180.402% |
United Health Products, Inc. | 284.64 Thousand USD | -725.087% |
Vasamed, Inc. | 1.6 Million USD | -46.762% |
Wearable Health Solutions, Inc. | 223.17 Thousand USD | -952.345% |